Results 241 to 250 of about 11,281,730 (290)

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Naming practice effects and inconsistencies relate to treatment outcome in people with aphasia. [PDF]

open access: yesNeuropsychologia
Wilmskoetter J   +12 more
europepmc   +1 more source

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

Treatment outcome and its predictors among patients with status epilepticus in Africa: A systematic review and meta-analysis. [PDF]

open access: yesExplor Res Clin Soc Pharm
Geremew GW   +14 more
europepmc   +1 more source

Turbulent-like Dynamics Predict Treatment Outcome in Major Depressive Disorder

open access: yes
Ruhe H   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy